Hints and tips:
...Proxima Fusion, incorporated in January, aims to build a complex device known as a stellarator and is the latest company to join the emerging fusion industry’s effort to generate electricity by fusing atoms...
...One risk could be a shortage in the global supply of plasma, which CSL needs to produce its treatments, as the coronavirus has disrupted blood donations in the US....
...Bill Mezzanotte, executive vice-president at CSL Behring, another company working on the approach, said: “Everybody recognises the need to re-engineer the process....
...Biotech group CSL has bought a blood collection company to fix its supply problems in China, as part of its ambition to be the country’s biggest plasma collector....
...Wuhan Zhong Yuan Rui De Biologics, the Chinese blood plasma company....
...“Plasma product demand is growing faster than supply,” said Ben Yang, China general manager for CSL’s US subsidiary CSL Behring....
...CSL, the Australian blood plasma company, will expand its footprint in China after announcing the acquisition of an 80 per cent stake in Chinese plasma fractionator Wuhan Zhong Yuan Rui De Biologics for...
...The blood plasma company draws just over 40 per cent of its revenues from the US and also reports in US dollars....
...UBS’s Mr Goodsall said Shire’s bid for Baxalta suggests big pharma may see opportunity in the blood plasma sector and could generate interest in CSL....
...Approval was easy for the $3.4bn cash and stock acquisition of Talecris, the US blood plasma company, by Grifols, its Spanish peer....
...Cerberus, best-known for its ill-fated investment in carmaker Chrysler, has no investments in Australia, although it tried to sell its Talecris blood plasma unit to CSL, a deal blocked by competition authorities...
...From what resembles a plasma TV, this Werther summons video images of the woman in his scruffy room; their ultimate meeting mingles dream fantasy, wish fulfilment and brutal reality, with the protagonist...
...Grifols, which is still part-owned and run by the Grifols founding family in Spain, said the deal would create one of the world’s leading suppliers of plasma protein therapeutics products....
...CSL in June had its $3.1bn takeover of Talecris Biotherapeutics, a US plasma provider, blocked on competition grounds....
...He expects that 3D sets will attract a premium over conventional LCDs and plasma sets but that this will be limited as suppliers will not want to price themselves out of the market....
...The buy-out firm struck a $3.1bn deal last year to sell Talecris to Australian vaccine maker CSL....
...However, CSL and Talecris maintained that the deal would improve plasma supplies in the US....
...CSL, the world’s second-largest maker of blood plasma products, said it will repurchase as much as 9% of its stock for about A$1.6bn ($1.3bn)....
...The US Federal Trade Commission authorised a lawsuit on Wednesday to block the proposed $3.1bn acquisition of Talecris, a US plasma provider, by Australia’s CSL, citing concerns over US antitrust laws....
...“I’m particularly surprised and disappointed with the commission’s theory that there is any coordination in the plasma industry,” Brian McNamee, CSL chief executive said....
...CSL and Talecris took issue with that assessment, claiming that the deal would improve plasma supplies in the US....
...CSL, Australian blood plasma products maker, said US regulators were likely to block its planned $3.1bn takeover of US rival Talecris Biotherapeutics....
...CSL, Australian blood plasma products maker, said that US regulators are likely to block its planned $3.1bn takeover of US rival Talecris Biotherapeutics....
...CSL looking for blood CSL wasted little time slapping on the war paint on Friday after a US regulator moved to block the Australian blood plasma group’s $3.1bn takeover of its smaller US rival Talecris....
...CSL, the world’s second largest blood plasma maker, rose as much as 5.8 per cent after saying it would abandon a $3.1bn plan to buy Talecris Biotherapeutics after regulators rejected the bid....
International Edition